.Nature Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for inclusion of people with MASLD and also measurement of liver end results in cardio-- renal-- metabolic tests, when records advise mechanistically conceivable benefits and professional safety-- and also lays out factors for trial style and also regulatory approval.